Life Sciences

InnoMed receives FDA warning letter for alleged GMP violations

Device Regulation Alert: Safety, Compliance and Reimbursement News, February 2, 2009

InnoMed failed to abide by current Good Manufacturing Practices (GMPs) at its Coconut Creek, FL, facility, according to an FDA warning letter.

Read more about InnoMed's warning letter on our Web site.

Comments

0 comments on “InnoMed receives FDA warning letter for alleged GMP violations

 

Most Popular